The reaction of 3-aminopropylamide of cholic acid with CS 2 produced a bile acid derivative of dithiocarbamic acid which further formed an ammonium salt with another molecule of 3-aminopropylamide of cholic acid. The cationic 3-ammonium propylamide of cholic acid did not react further with CS 2 and the formed salt was stable in the reaction mixture, even when excess CS 2 was used. When the reaction was carried out in the presence of aqueous sodium hydroxide, only the bile acid derivative of sodium dithiocarbamate was formed. The dithiocarbamate derivatives were characterized by 1 H-and 13 C-NMR spectroscopy and ESI-TOF mass spectrometry.
Introduction
It is known that amines react with CS 2 forming dithiocarbamates [1] [2] [3] [4] [5] [6] . Recently, Yavari et al. [7] have reported new synthetic strategies to prepare dithiocarbamates due to their large application potential. Dithiocarbamates exhibit numerous biological activities [9] [10] [11] [12] and they are used in agriculture [12] [13] [14] and as linkers in solid-phase organic synthesis [15] [16] [17] . Further, dithiocarbamates are also widely used in medicinal chemistry and they have found application in cancer therapy [18, 19] . As a biologically important expansion of the topic, we now present the synthesis and characterization of cholic acid-derived ammonium dithiocarbamates. This straightforward synthetic method offers an effective route to bile acid derivatives with increased water solubility, which is an essential property in
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the design of physiologically active receptors [20, 21] and drug carriers [22] . The synthetic route and numbering of 2 are shown in Scheme 1.
Results and Discussion

Chemistry
As the first step, N-(3-aminopropyl)-3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholan-24-amide (1) was prepared by a reaction of methyl cholate (methyl 3-alpha,7-alpha,12-alpha-trihydroxy-5-betacholan-24-oate) with 1,3-diaminopropane (7 days at r.t.) [23] . Then compound 1 was allowed to react with CS 2 in methanol to form the desired product, N- (3- 
Spectroscopy
The structural characterization of 2 is based on one-dimensional 1 H-, 13 C-, and 13 and 23 of the bile acid moieties in both ionic species overlap. For the assignment of the 13 C-NMR spectrum ( Figure 3 and Table 1 ) the reference data [30] and heteronuclear chemical shift correlation measurements PFG 1 H, 13 C HMQC and HMBC were used. Unfortunately the ammonium dithiocarbamate moiety of 2 was not thermally stable and it degraded in one week, whereas the sodium salt remained unchanged for several months when stored at room temperature. 
Experimental
General
All reagents and solvents of analytical grade were purchased from Sigma-Aldrich and were used without further purification.
1 H-and 13 C-NMR experiments were run on a Bruker Avance DRX 500
FT NMR spectrometer equipped with a 5 mm diameter inverse detection probehead and z-gradient accessory.
1
H chemical shifts were referenced to the center peak of the CD 2 HOD quintet δ( 1 H) = 3.31 ppm and 13 C chemical shifts to the center peak of the CD 3 OD heptet δ( 13 C) = 49.15 ppm from the internal TMS. Mass spectra were run with a QSTAR Elite MS/MS mass spectrometer system. Elemental analyses were performed on a Perkin Elmer 2400, series II, CHNS/O analyzer. (2) 3-Aminopropylamide of cholic acid (1) (100 mg, 0.22 mmol) and CS 2 (30 μL, 0.50 mmol) were dissolved in methanol (10 mL) and stirred overnight at room temperature. After that the solvent and an excess CS 2 was removed in vacuo. Yield 100%. 
Synthesis of N-(3-aminopropyl)-3-α,7-α,12-α-trihydroxy-5-β-cholan-24-oyl ditihiocarbamate of N-(3-ammoniumpropyl)-3-α,7-α,12-α-trihydroxy-5-β-cholan-24-oic acid amide
Conclusions
We have demonstrated the straightforward synthesis of the cholic acid derived ammonium dithiocarbamate in both ionic species in 100% yield. We are planning to extend this approach starting from other ω-aminoalkylamides of other bile acids. The sodium salts of their dithiocarbamates are very promising starting materials in the preparation of dithiocarbamate gold(III) complexes, which have been shown to possess cytotoxic properties. They are being evaluated as potential antitumor agents as an alternative to cisplatin [18, [31] [32] [33] .
